Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icariin to Prevent Corticosteroid-related Memory Changes
NCT02112123Phase 1Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Apr 2014
- Primary completion
- Sep 2016
- Modality
- Nucleic Acid-Directed Small Molecules, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of icariin in Memory impairment (6 arms), sponsored by UT Southwestern Medical Center. Primary endpoint: Blood concentration levels of icariin at 24 hours. Started Apr 2014; status: completed.
02
Drugs
icariin
03
Conditions
Memory impairment
Beyond the preview
Go deeper on NCT02112123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02112123.